http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2189754-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98d9ce8ebef9c8d86afda666fe05b068
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-3581
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-1455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-6826
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-1455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
filingDate 1995-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_285177aafec422dedf7f83e5d4dd49aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_073c0a510ad8fa35bd507f3a3a3d182d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13cec7fab609552913df030ff63c68c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e85762ee23cc83910a39ce77e298289
publicationDate 1995-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2189754-A1
titleOfInvention Self-Emission Noninvasive Infrared Spectrophotometer
abstract A method and apparatus for monitoring glucose, ethyl alcohol and other blood constituents in a noninvasive manner. The measurements are made by monitoring infrared absorption of the desired blood constituent in the long infrared wavelength range where the blood constituent has a strong and distinguishable absorption spectrum. The long wavelength infrared energy emitted by the person as heat is monitored and the infrared absorption of particular constituents in the blood (such as glucose or blood alcohol) is measured by infrared detector (412) at characteristic infrared absorption wavelengths for those constituents. The measurements are preferably synchronized with systole and diastole of the cardiac cycle monitored by cardiac monitor (718) so that the signal contribution caused by veins and tissues (which do not pulse) may be cancelled by (418) when a ratio of the detected signals is taken. The concentration of the blood constituents is then determined in accordance with a polynomial equation.
priorityDate 1994-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410

Total number of triples: 26.